Stryker Reports Third Quarter 2025 Operating Results
Stryker (NYSE:SYK) reported operating results for the third quarter of 2025.
"We delivered another quarter of strong sales and double-digit adjusted earnings per share growth," said Kevin A. "Our teams continue to execute at a high level, driving performance at the high-end of MedTech and building sustained momentum across our broad portfolio."
Key highlights include:
- Consolidated net sales of $6.1 billion, a 10.3% increase in the quarter and 9.6% in constant currency.
- Organic net sales increased 9.5% in the quarter, with 9.1% from increased unit volume and 0.4% from higher prices.
- MedSurg and Neurotechnology net sales of $3.8 billion, a 14.4% increase in the quarter and 13.9% in constant currency.
- Orthopaedics net sales of $2 billion.
Author's summary: Stryker reports strong Q3 2025 results.
More News
- NYT Mini crossword answers, hints for October 31, 2025
- Bitches in Stitches: Northern Quarter's new all-female comedy shows - Mancunian Matters
- MEG takeover vote postponed again over questions about Cenovus-Strathcona side deal
- Best gaming monitor deal: Save $500 on Samsung 57-inch Odyssey Neo G9
- 'The need for hospices is becoming ever more vital'
- MEG Delays Vote on $5.4B Oil Takeover Yet Again
- Ayuba Sylvester James: “For MCP to Rise, Chakwera Must Fall” - Malawi Nyasa Times - News from Malawi about Malawi
- FCC circulates proposal for more C-Band auctions
- Cenovus announces third-quarter 2025 results
- Sharks Locker Room: Best 2-Week Stretch of Hockey in Years?